HOOKIPA’s platform capitalizes on several natural advantages of the arenavirus to deliver differentiated clinical benefits (Fig. 1). First, arenaviruses efficiently target and infect antigen ...

Centers for Disease Control and Prevention-led research demonstrates that an oral antiviral drug, 4′-fluorouridine (4′-FlU), effectively inhibits lethal arenavirus infections in animal models.